A Novel Frailty Grade Combined with Cachexia Index and Osteopenia in Esophagectomy
Keita Takahashi(Jikei University School of Medicine), Ken Eto(Jikei University School of Medicine), Takanori Kurogochi(The Jikei University Hospital), Yoshitaka Ishikawa(Jikei University School of Medicine), Fumiaki Yano(Jikei University School of Medicine), Takahiro Masuda(Jichi Medical University), Akira Matsumoto(Jikei University School of Medicine), Yuichiro Tanishima(Jikei University School of Medicine), Yujiro Tanaka(Jikei University School of Medicine), Masami Yuda(Jikei University School of Medicine)
Cited by 10
Related Papers
SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice
|American Journal of Physiology-Renal Physiology|2013|481
Increase in SGLT1-mediated transport explains renal glucose reabsorption during genetic and pharmacological SGLT2 inhibition in euglycemia
|American Journal of Physiology-Renal Physiology|2013|308
Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice
|American Journal of Physiology-Renal Physiology|2012|158
Osmotic diuresis by SGLT2 inhibition stimulates vasopressin‐induced water reabsorption to maintain body fluid volume
|Physiological Reports|2020|135